Bernardo Bonilauri

Instructor @StanfordCVI | AHA CDA @American_Heart | Exploring cryptic peptides, misfolded proteins, and non-canonical codes. Historian by avocation.

[Bernardo Bonilauri @BBonilauri]

The long non-coding RNA landscape of endurance exercise training #Exercise, #Endurance, #MoTrPAC, #lncRNAs, #Multiomics @MolMetab
https://t.co/23WsqUxBbE

[bioRxiv Molecular Biology @biorxiv_molbio]

Discovery of the TGCB microprotein translated from the lncRNA CHASERR https://t.co/RQyChTOdq1 #biorxiv_molbio

[Bernardo Bonilauri @BBonilauri]

The Long Non-coding RNA Landscape of Endurance Exercise Training
#lncRNAs #exercise #endurance #noncoding #multiomics #omics
https://t.co/SysiFw1mFc

[Bernardo Bonilauri @BBonilauri]

The Evolving Landscape of Amyloid Research
#amyloid #amyloidosis #AI #NLM
PROTEINS: Structure, Function, and Bioinformatics | Protein Science Journal | Wiley Online Journal https://t.co/lVzLqXGk63

[Bernardo Bonilauri @BBonilauri]

Environmental and phytohormone modulation of organ‐specific specialized metabolite profiles in the dryland tree Erythrina velutina - Chacon - Plant Biology - Wiley Online Library #phytohormone #metabolites #Erythrina #PlantBiology https://t.co/zO9hjdPLWO

[Bernardo Bonilauri @BBonilauri]

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
https://t.co/Ur40DgRveN

[NEJM @NEJM]

Presented at #ESCardio:

Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo. Full HELIOS-B trial results: https://t.co/3MZy3lLznK

[Bernardo Bonilauri @BBonilauri]

Unveiling Polysomal Long Non-Coding RNA Expression on the First Day of Adipogenesis and Osteogenesis in Human Adipose-Derived Stem Cells https://t.co/a19bCd6Cq4 #Polysome #lncRNAs #adipogenesis #osteogenesis #differentiation #stemcells @IJMS_MDPI

[Journal of Molecular Pathology MDPI @JMP_MDPI]

Welcome to read the latest publication from the Journal of #Molecular #Pathology: Exploring the Molecular Pathology of #Iatrogenic #Amyloidosis, by Dr. Bernardo Bonilauri @BBonilauri from Stanford University @StanfordCVI

🔗https://t.co/Ames9gNnXG
#PathTwitter #pathologist #JMP

[Lisa Wilsbacher @LWilsbacher]

Claim your spot in the Genomic and Precision Medicine Early Career competition at #AHA24 in Chicago, Nov. 16-18
Submit your science by June 6, then apply!
To learn more, visit https://t.co/q9bQJJR6z0
#AHA100years
@AHAScience @GenPrecisionMed

[Cell @CellCellPress]

In the latest issue! Structural evolution of fibril polymorphs during amyloid assembly https://t.co/NPnlSYhbfI

[Pradeep Natarajan @pnatarajanmd]

Among nearly 1M in Europe getting CT scans at 10-22y (without cancer diagnosed 1y after CT) followed mean 7.8y, there was a dose-dependent response of radiation exposure to heme malignancy risk.
Would suspect higher rates of clonal hematopoiesis as well...
https://t.co/8Riumxj34B @NatureMedicine

[JAMA Cardiology @JAMACardio]

An analysis of Tafamidis in Transthyretin Cardiomyopathy Clinical Trial found tafamidis 80 mg, compared w/ placebo, attenuated the decline in left ventricular systolic & diastolic function in patients w/ transthyretin amyloid cardiomyopathy over 30 mos. https://t.co/1J8xvup4w3

[Bernardo Bonilauri @BBonilauri]

Absolutely inspired by the profound and motivational words by my mentor @Joseph_C_Wu, AHA president. Grateful for the chance to contribute to cardiovascular research in this remarkable lab. Thrilled to be part of this history! #AHA23 @American_Heart @AHAScience

[Bernardo Bonilauri @BBonilauri]

What a great panel and discussion! State-of-the-art of Precision Medicine and Gene Therapy in Cardiac Diseases! @American_Heart @AHAScience #AHA23
#CardioTwitter #Cardiology #GeneTherapy #Heart

[Bernardo Bonilauri @BBonilauri]

Great talk about gene replacement therapy for cardiac diseases by Dr. Adam Helms @AdamHelmsMD
"Next Steps: When is the Right Time for First in Human Gene Therapy? Considering the Disease and Prior Models" #AHA23 #CardioTwitter #GeneTherapy @AHAScience @American_Heart

[Bernardo Bonilauri @BBonilauri]

Special talk about Precision Medicine in Amyloidosis diseases by Dr. Kevin Alexander @KMAlexanderMD
"Amyloid: Precision Medicine at its Best - From Diagnosis to Therapeutics" #AHA23 #CardioTwitter #Amyloid #ATTR @AHAScience @American_Heart

[Bernardo Bonilauri @BBonilauri]

Great perspective about gene therapy for cardiac diseases by Dr. Eric Adler @EricAdler17
"From Delivery to Targets: Advances in AAV Delivery and Targets on the Horizon" #AHA23 #CardioTwitter #Cardiology #GeneTherapy @AHAScience @American_Heart

[Bernardo Bonilauri @BBonilauri]

Special talk from Dr. Carolyn Ho @CarolynHoMD about Precision Medicine. "Precision Medicine Drives Individualized Care: How Genetics Can Inform Novel and Emerging Therapies" #AHA23 #CardioTwitter #HCM #DCM @AHAScience @American_Heart

[Bernardo Bonilauri @BBonilauri]

Amazing talk about the use of AI on HF diagnostic by Dr. Faraz Ahmad @FarazAhmadMD "Advanced Diagnostics in HF: The Role of Artificial Intelligence, -Omics, and Deep Phenotyping" #AHA23 #CardioTwitter #AI #HFpEF @AHAScience @American_Heart